Trade ORIC stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Oric Pharmaceuticals, Inc. (ORIC) is trading at US$11.99, down 0.33% today as of Oct 9, 16:00 EDT. The company has a market capitalisation of US$1.47B. Over the past 52 weeks, ORIC has traded between US$7.23 and US$14.68. On Syfe you can trade ORIC with $0 commission and add it to your watchlist.
| Previous close | US$12.03 |
|---|---|
| Market cap | US$1.47B |
| 52-week range | US$7.23 – US$14.68 |
| Volume | 1.09M |
| Exchange | US |
Oric Pharmaceuticals, Inc.
Oric Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in the development of cancer treatments that address mechanisms of therapeutic resistance. It specializes in hormone-dependent cancers, key tumor dependencies, and precision oncology. The company was founded by Charles L. Sawyers, Richard A. Heyman, and Scott Lowe in 2014 and is headquartered in South San Francisco, CA.
Year: 2020
Oric Pharmaceuticals Insider Sold Shares Worth $1,053,814, According to a Recent SEC Filing
Aug 28, 8:19 PM · MT Newswires
ORIC Pharmaceuticals Starts Phase 3 Trial of Rinzimetostat in Metastatic Prostate Cancer
Jul 14, 9:07 PM · MT Newswires
Oric Pharmaceuticals, Inc. (ORIC) stock is trading at US$11.99, -0.33% from the previous close of US$12.03.
The market cap for Oric Pharmaceuticals, Inc. (ORIC) stock is approximately US$1.47B.
The 52-week high for Oric Pharmaceuticals, Inc. (ORIC) stock is US$14.68.
The 52-week low for Oric Pharmaceuticals, Inc. (ORIC) stock is US$7.23.
Oric Pharmaceuticals, Inc. (ORIC) does not currently pay a dividend.
Stay on top of ORIC
Price moves, news and earnings — straight to your inbox.
Snapshot
Popular Stocks in Singapore
